Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Gastroenterology and Hepatology 3, 657 (1 December 2006) | doi:10.1038/ncpgasthep0651
Low-dose warfarin improves survival in patients with inoperable pancreatic carcinoma
Abstract
Nakchbandi W et al. (2006) Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma. Scand J Gastroenterol 41: 1095–1104 Pancreatic carcinoma is associated with thromboembolism, caused by increased levels of coagulation factors and decreased thrombolysis.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
